CLINICAL_TRIALS
research
· 2026-04-21
Clinical Trial Update: A Gaucher Disease Gene Therapy Trial With FLT201 [Phase 3]
Summary
A Phase 3 Gaucher disease type 1 gene therapy trial (FLT201) is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spur Therapeutics | Conditions: Gaucher Disease Type 1 | Phase 3 | Status: RECRUITING